FDA 510(k)
FDA class 2
Substantially Equivalent
🇺🇸 United States
Sensititre YeastOne Susceptibility System with Voriconazole in the dilution range of 0.008 - 8 ug/mL
K Number: K211539
·
Decision Dec 15, 2021
Classifications
1
FEI Numbers
8
Registration Numbers
8
Same Product Code
20
Applicant Total
64
Review Days
211
Research this 510(k) in seconds
The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.
Free to try · every answer cites its records
Basic Information
- Device Name
- Sensititre YeastOne Susceptibility System with Voriconazole in the dilution range of 0.008 - 8 ug/mL
- K Number
- K211539
- Device Class
- FDA class 2
- Clearance Type
- Traditional
- Regulation Number
- 866.1640
- Medical Specialty
- Microbiology
- Decision
- Substantially Equivalent
- Statement or Summary
- Statement
- Applicant
- Thermo Fisher Scientific
- Date Received
- May 18, 2021
- Decision Date
- December 15, 2021
- Product Code
- NGZ
- Advisory Committee
- Microbiology
- Review Advisory Committee
- MI
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| NGZ | Susceptibility Test Plate, Antifungal | FDA class 2 | Microbiology |
Similar 510(k) Clearances
Other 510(k) clearances with the same product code (NGZ), ordered by most recent decision date.
The Sensititre YeastOne Susceptibility System with Micafungin in the dilution range of 0.008-16 µg/mL
FDA 510(k)
FDA Class 2
·Microbiology
VITEK 2 AST-Yeast Voriconazole (<= 0.03125 - >= 4 µg/mL)
FDA 510(k)
FDA Class 2
·Microbiology
VITEK 2 AST-Yeast Anidulafungin (<= 0.015 - >= 8 µg/mL)
FDA 510(k)
FDA Class 2
·Microbiology
The Sensititre YeastOne Susceptibility System with Rezafungin in the dilution range of 0.008-8ug/mL
FDA 510(k)
FDA Class 2
·Microbiology
Sensititre YeastOne Susceptibility System with Fluconazole in the dilution range of 0.12-128ug/mL
FDA 510(k)
FDA Class 2
·Microbiology
The Sensititre YeastOne Susceptibility System with Caspofungin in the dilution range of 0.015-16ug/ml
FDA 510(k)
FDA Class 2
·Microbiology
Other Clearances by Thermo Fisher Scientific
| K Number | Device Name | ||
|---|---|---|---|
| K252062 | The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Colistin in the dilution range of 0.12-16 ug/mL | Sep 25, 2025 | Substantially Equivalent |
| K250575 | The Sensititre 18 - 24 hour MIC or Breakpoint Susceptibility System with Aztreonam/avibactam in the dilution range of 0.008/4 - 64/4 ug/mL | Sep 5, 2025 | Substantially Equivalent |
| K252014 | The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Amikacin in the dilution range of 0.25-256 ug/mL | Aug 28, 2025 | Substantially Equivalent |
| K250990 | The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Ciprofloxacin in the dilution range of 0.002-64 ug/mL | Jun 30, 2025 | Substantially Equivalent |
| K242843 | The Sensititre 20-24 hour Haemophilus influenzae/Streptococcus pneumoniae (HP) MIC or Breakpoint Susceptibility System with Ceftobiprole in the dilution range of 0.008-16 ug/mL. | Jun 20, 2025 | Substantially Equivalent |
| K242659 | The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Vancomycin in the dilution range of 0.25-128 ug/mL | May 22, 2025 | Substantially Equivalent |
| K242658 | The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Moxifloxacin in the dilution range of 0.008-16 ug/mL | Apr 15, 2025 | Substantially Equivalent |
| K243738 | The Sensititre YeastOne Susceptibility System with Micafungin in the dilution range of 0.008-16 µg/mL | Feb 27, 2025 | Substantially Equivalent |
| K243201 | The Sensititre 20-24 hour Haemophilus influenzae/Streptococcus pneumoniae (HP) MIC or Breakpoint Susceptibility System with penicillin in the dilution range of 0.015-32 ug/mL | Feb 10, 2025 | Substantially Equivalent |
| K242905 | The Sensititre 20-24 hour Haemophilus influenzae/Streptococcus pneumoniae (HP) MIC or Breakpoint Susceptibility System with Linezolid in the dilution range of 0.12-32 ug/mL | Feb 10, 2025 | Substantially Equivalent |